Literature DB >> 9686055

[Cutaneo-mucous manifestations of dengue].

F Desruelles1, I Lamaury, M Roudier, R Goursaud, A Mahé, J Castanet, M Strobel.   

Abstract

OBJECTIVES: To describe muco-cutaneous manifestations of dengue fever, assessing their incidence and histopathological aspects. PATIENTS AND METHODS: During a dengue 2 epidemic, occurring in Guadeloupe in 1994, all patients admitted with a confirmed diagnostic of dengue fever were assessed for dermatological changes by 2 clinicians; 5 patients underwent skin biopsy with immuno-fluorescence staining.
RESULTS: Among 39 adult inpatients (Sex ratio 1.1, medium age 41 years) none presented a severe form of the disease, whereas 18/39 (46 p. 100) had some muco-cutaneous changes, associating rash (13 cases (33 p. 100)), mucous membranes involvement (7 cases (18 p. 100)), or minor haemorrhages (6 cases (15 p. 100)). The rash appeared macular, discrete, itching, troncular with peripheral extension, rather than maculo-papular (morbiliform) as usually described. Apart from cases which minor haemorrhagic changes, significatively associated with marked thrombocytopenia (medium 37 x 10(9)/1), dengue cases either with or without muco-cutaneous changes had similar clinical (duration, severity) or biological (neutro-lympho-thrombocytopenia, transaminases) features, and evolution. Histological changes appeared non specific (minor lymphocytic dermal vasculitis, non contributive immuno-fluorescence). DISCUSSION: Clinical and histological features of the rash are unspecific and inconstant: they do not allow an easy and accurate diagnosis. Complete clinical, epidemiological (very recent travel in endemic areas) or biological data should be collected, and early virological or later serological confirmation is needed. As well as travel facilities are growing, the dengue area is extending: dengue fever should therefore be considered in every traveller with fever and rash.

Entities:  

Mesh:

Year:  1997        PMID: 9686055

Source DB:  PubMed          Journal:  Ann Dermatol Venereol        ISSN: 0151-9638            Impact factor:   0.777


  6 in total

1.  Clinical profile and outcome of Dengue fever cases.

Authors:  Vinod H Ratageri; T A Shepur; P K Wari; S C Chavan; I B Mujahid; P N Yergolkar
Journal:  Indian J Pediatr       Date:  2005-08       Impact factor: 1.967

Review 2.  Dengue: Moving from Current Standard of Care to State-of-the-Art Treatment.

Authors:  Victor C Gan
Journal:  Curr Treat Options Infect Dis       Date:  2014

Review 3.  Emerging and changing viral diseases in the new millennium.

Authors:  C Scully; L P Samaranayake
Journal:  Oral Dis       Date:  2015-08-06       Impact factor: 3.511

Review 4.  New and emerging infectious diseases.

Authors:  Dirk M Elston
Journal:  J Am Acad Dermatol       Date:  2005-06       Impact factor: 11.527

5.  Expanded dengue syndrome with small-medium-vessel vasculitis: A case report.

Authors:  Augustine Jose; Minakshi Dhar; Prasan Kumar Panda; Sanjeev Kishore
Journal:  Int J Crit Illn Inj Sci       Date:  2021-03-27

6.  Skin dendritic cell and T cell activation associated with dengue shock syndrome.

Authors:  Huynh Thi Le Duyen; Daniela Cerny; Dinh The Trung; Jassia Pang; Sumathy Velumani; Ying Xiu Toh; Phan Tu Qui; Nguyen Van Hao; Cameron Simmons; Muzlifah Haniffa; Bridget Wills; Katja Fink
Journal:  Sci Rep       Date:  2017-10-27       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.